Main menu

NEW YORK (GenomeWeb) – Monsanto announced today that it has licensed a CRISPR technology platform from Korean biotechnology company ToolGen with the intention of developing agricultural products.

The global license provides Monsanto with access to ToolGen's comprehensive suite of CRISPR intellectual property for use in plants. The agreement will also expand Monsanto's portfolio of gene editing tools, which the company plans to use to develop improved and sustainable crops.